Suppr超能文献

靶向微小RNA干扰促进出生后心脏细胞周期重新进入。

Targeted MicroRNA Interference Promotes Postnatal Cardiac Cell Cycle Re-Entry.

作者信息

Zhang Yiqiang, Matsushita Noriko, Eigler Tamar, Marbán Eduardo

机构信息

Department of Medicine/Cardiology, University of Washington, USA ; Cedars-Sinai Heart Institute, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

Cedars-Sinai Heart Institute, 8700 Beverly Boulevard, Los Angeles, CA 90048, USA.

出版信息

J Regen Med. 2013;2:2. doi: 10.4172/2325-9620.1000108.

Abstract

Mammalian heart cells undergo a marked reduction in proliferative activity shortly after birth, and thereafter grow predominantly by hypertrophy. Our understanding of the molecular mechanisms underlying cardiac maturation and senescence is based largely on studies at the whole-heart level. Here, we investigate the molecular basis of the acquired quiescence of purified neonatal and adult cardiomyocytes, and use microRNA interference as a novel strategy to promote cardiomyocyte cell cycle re-entry. Expression of cyclins and cyclin-dependent kinases (CDKs) and positive modulators were down-regulated, while CDK inhibitors and negative cell cycle modulators were up-regulated during postnatal maturation of cardiomyocytes. The expression pattern of microRNAs also changed dramatically, including increases in miR-29a, miR-30a and miR-141. Treatment of neonatal cardiomyocytes with miRNA inhibitors anti-miR-29a, anti-miR-30a, and antimiR-141 resulted in more cycling cells and enhanced expression of Cyclin A2 (CCNA2). Thus, targeted microRNA interference can reactivate postnatal cardiomyocyte proliferation.

摘要

哺乳动物心脏细胞在出生后不久增殖活性就会显著降低,此后主要通过肥大生长。我们对心脏成熟和衰老潜在分子机制的理解很大程度上基于全心脏水平的研究。在这里,我们研究纯化的新生和成年心肌细胞获得性静止的分子基础,并使用微小RNA干扰作为促进心肌细胞重新进入细胞周期的新策略。在心肌细胞出生后成熟过程中,细胞周期蛋白、细胞周期蛋白依赖性激酶(CDK)及其正向调节因子的表达下调,而CDK抑制剂和负向细胞周期调节因子上调。微小RNA的表达模式也发生了显著变化,包括miR-29a、miR-30a和miR-141的增加。用微小RNA抑制剂抗miR-29a、抗miR-30a和抗miR-141处理新生心肌细胞,导致更多的循环细胞和细胞周期蛋白A2(CCNA2)表达增强。因此,靶向微小RNA干扰可以重新激活出生后心肌细胞的增殖。

相似文献

5
Cell cycle regulation in mouse heart during embryonic and postnatal stages.胚胎期和出生后阶段小鼠心脏中的细胞周期调控。
Dev Growth Differ. 2012 Oct;54(8):731-8. doi: 10.1111/j.1440-169X.2012.01373.x. Epub 2012 Sep 7.

引用本文的文献

7
Non-coding RNA therapeutics for cardiac regeneration.非编码 RNA 治疗心脏病再生。
Cardiovasc Res. 2021 Feb 22;117(3):674-693. doi: 10.1093/cvr/cvaa071.
8
Gene Therapy for Heart Failure: New Perspectives.心力衰竭的基因治疗:新视角
Curr Heart Fail Rep. 2018 Dec;15(6):340-349. doi: 10.1007/s11897-018-0410-z.

本文引用的文献

2
5
Stem cell therapy for cardiac disease.干细胞治疗心脏病。
Pediatr Res. 2012 Apr;71(4 Pt 2):491-9. doi: 10.1038/pr.2011.61. Epub 2012 Feb 8.
6
Empowering adult stem cells for myocardial regeneration.赋予成人干细胞心肌再生的能力。
Circ Res. 2011 Dec 9;109(12):1415-28. doi: 10.1161/CIRCRESAHA.111.243071.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验